You are here

Clinical Trials: Central Nervous System Diseases



Each Clinical Trial will open in a new browser window or tab.

Return to Clinical Trials Page

Posted: Wednesday, August 26, 2015 - 12:00
Condition:   Cerebellar Ataxia
Interventions:   Biological: Stemchymal®;   Procedure: Excipients
Sponsor:   Steminent Biotherapeutics Inc.
Recruiting - verified April 2016
Posted: Sunday, July 26, 2015 - 12:00
Condition:   Acute Spinal Cord Injury
Intervention:   Device: Functional collagen scaffold
Sponsors:   Chinese Academy of Sciences;   Affiliated Hospital of Logistics University of CAPF;   The First Affiliated Hospital of Soochow University
Recruiting - verified July 2015
Posted: Thursday, July 2, 2015 - 12:00
Condition:   Stroke
Intervention:   Biological: Human umbilical cord mesenchymal stem cells
Sponsor:   Affiliated Hospital to Academy of Military Medical Sciences
Not yet recruiting - verified July 2015
Posted: Wednesday, June 24, 2015 - 12:00
Condition:   Amyotrophic Lateral Sclerosis
Intervention:   Biological: mesenchymal stem cells
Sponsor:   Royan Institute
Recruiting - verified December 2015
Posted: Thursday, June 18, 2015 - 12:00
Condition:   Epilepsy, Unspecified, Intractable
Interventions:   Other: IVIG;   Drug: Prednisolone
Sponsor:   Seoul National University Hospital
Recruiting - verified February 2016
Posted: Monday, June 15, 2015 - 12:00
Condition:   Nerve and Spinal Cord Injuries
Intervention:   Biological: Umbilical Cord Mesenchymal Stem Cells
Sponsor:   Limin Rong
Recruiting - verified June 2015
Posted: Thursday, June 11, 2015 - 12:00
Condition:   Amyotrophic Lateral Sclerosis
Intervention:   Biological: Q-Cells
Sponsor:   Q Therapeutics, Inc.
Not yet recruiting - verified June 2015
Posted: Thursday, May 21, 2015 - 12:00
Condition:   Amyotrophic Lateral Sclerosis
Interventions:   Drug: Ezogabine;   Drug: Placebo
Sponsors:   Brian Wainger;   ALS Association;   GlaxoSmithKline;   Harvard University;   Massachusetts General Hospital
Posted: Monday, May 18, 2015 - 12:00
Condition:   Parkinson Disease
Intervention:   Biological: ISC-hpNSC
Sponsor:   Cyto Therapeutics Pty Limited
Recruiting - verified February 2016
Posted: Friday, May 15, 2015 - 12:00
Condition:   Chronic Ischemic Stroke
Interventions:   Biological: SB623 Implant (2.5M);   Biological: SB623 Implant (5.0M);   Procedure: Sham surgery
Sponsors:   SanBio, Inc.;   Sunovion
Recruiting - verified April 2016